Pathophysiology of interstitial lung diseases

The pathophysiological understanding of interstitial lung diseases (ILDs) has made impressive progress over the last years leading to approved therapies and an increasing number of promising drug candidates currently tested in clinical trials. In our online seminar, an interdisplinary panel of leaders in the field will present their novel data on target identification, large scale tissue omics and image omics in the ILDs.






16.00 - 18.00 CEST


16.oo hWelcome
Oliver Distler, Zurich, Switzerland
16.05 hTarget identification and drug discovery in pulmonary fibrosis
Melanie Königshoff, Division of Pulmonary, Allergologoy and Critical Care Medicine, University of Pittsburgh, USA
16.40 hPathophysiology of Pulmonary Fibrosis – Lessons from the Human Lung
Naftali Kaminski, Pulmonary Critical Care and Sleep Medicine, Yale School of Medicine, USA
17.15 hApplication of Image-Omics in Interstitial Lung Diseases
Janine Schniering, Helmholtz Munich, German Research Center for Environmental Health, Neuherberg, D
17.50 hSummary and conclusion
Oliver Distler, Zurich, Switzerland


Start Zoom Meeting

Meeting-ID: 613 9961 2747
Kenncode: 210976


Nicole Schneider

Verantwortlicher Fachbereich

This site is registered on as a development site. Switch to a production site key to remove this banner.